Select Page

Home » David Adamson, MD, CEO & Founder, ARC Fertility Co-Authors Study on Equitable Access to Assisted Reproductive Technology, Publishes in British Medical Journal

David Adamson, MD, CEO & Founder, ARC Fertility Co-Authors Study on Equitable Access to Assisted Reproductive Technology, Publishes in British Medical Journal

by | May 14, 2024 | Fertility Blog, News, News & Events, Press, Press Releases

CUPERTINO, Calif.–(BUSINESS WIRE)–ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, is proud to announce the publication of “Achieving more equitable access to assisted reproduction,” in the British Medical Journal (BMJ). In this study, David Adamson, MD, founder and CEO, ARC joins co-authors S.J. Dyer, M.C. Inhorn, and F. Zegers-Hochschild in advocating for more inclusive fertility treatment, emphasizing the importance of social action to address the burden of infertility.

“This paper highlights the critical intersection of societal priorities and individual human rights in addressing the global health problem of infertility and calls for harmonization of these priorities to create a more balanced approach to infertility treatment.”

“Infertility compromises the human right to have children and build a family,” says Dr. Adamson. “This paper highlights the critical intersection of societal priorities and individual human rights in addressing the global health problem of infertility and calls for harmonization of these priorities to create a more balanced approach to infertility treatment.”

The World Health Organization (WHO) has recognized infertility as a significant global health issue, impacting 1 in 6 couples in their lifetimes. Assisted reproductive technology (ART) has proven to be a safe and effective intervention, leading to the birth of over 10 million babies worldwide. However, persistent disparities in access to ART highlight the need for more comprehensive and equitable reproductive health policies.

“Equitable access to ART requires a collective, worldwide effort to recognize the impact of infertility and the necessity to provide accessible treatment as part of enabling reproductive rights,” says Dr. Adamson. “This study sheds light on the crucial need to integrate fertility care into broader reproductive health priorities. As we move forward, it’s essential to ensure that policies and practices align with both societal needs and individual human rights to build a more inclusive future for fertility care.”

About ARC® Fertility

ARC® Fertility was founded in 1997 from its founder’s passion to increase access to affordable, high-quality reproductive care for everyone. We are accomplishing our mission through our national network of top-tier fertility clinics and with the help of brokers, employers, health plans and TPAs. ARC physicians deliver high-value fertility and family-forming employer benefits through evidence-based treatment packages with externally validated superior outcomes at lower cost and innovative pricing. ARC provides comprehensive women’s health services through optional pharmacy, pregnancy, return to work, menopause and emotional health programs as well as financing directly to patients. ARC Fertility has helped tens of thousands of people create the family of their dreams. 

Skip to content